Detalhe da pesquisa
1.
Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
Am J Hematol
; 94(1): 46-54, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30290003
2.
First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
Am J Hematol
; 92(11): 1214-1223, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28815757
3.
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.
Blood
; 122(7): 1284-92, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23843494
4.
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.
Blood
; 122(6): 872-84, 2013 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23803709
5.
Epidemiology of chronic myeloid leukaemia: an update.
Ann Hematol
; 94 Suppl 2: S241-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814090
6.
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).
Eur J Haematol
; 94(3): 243-50, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082346
7.
Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.
Blood
; 119(25): 5963-71, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22508936
8.
Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response.
Eur J Haematol
; 92(5): 413-20, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24372965
9.
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score.
Blood
; 118(3): 686-92, 2011 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21536864
10.
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
Blood
; 118(12): 3228-35, 2011 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21685374
11.
Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.
Immunology
; 133(3): 296-306, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21463298
12.
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
Blood
; 113(19): 4497-504, 2009 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19264678
13.
The European LeukemiaNet: achievements and perspectives.
Haematologica
; 96(1): 156-62, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21048032
14.
T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies.
Immunology
; 131(3): 371-6, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20518821
15.
Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib.
Eur J Haematol
; 85(5): 399-404, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20659155
16.
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
N Engl J Med
; 355(23): 2408-17, 2006 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17151364
17.
The EUTOS CML score aims to support clinical decision-making.
Blood
; 119(12): 2966-7, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22442336
18.
Second-generation BCR-ABL kinase inhibitors in CML.
N Engl J Med
; 363(17): 1673; author reply 1673-5, 2010 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20973145
19.
Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia.
Biochem Biophys Res Commun
; 366(3): 848-51, 2008 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18082628
20.
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
N Engl J Med
; 348(11): 994-1004, 2003 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-12637609